PL EN


Preferences help
enabled [disable] Abstract
Number of results
2011 | 58 | 3 | 287-296
Article title

Conventional calpains and programmed cell death

Content
Title variants
Languages of publication
EN
Abstracts
EN
The evidence on the crucial role of a family of calcium-dependent cysteine proteases called calpains in programmed cell death is rich and still growing. However, understanding of the mechanisms of their functions in apoptosis is not full yet. Calpains have been implicated in both physiological and pathological cell death control, especially in various malignancies, but also in the immune system development and function. There is also growing evidence on calpain involvement in apoptosis execution in certain pathological conditions of the central nervous system, in cardiovascular diseases, etc. Understanding of the clinical significance of calpain activation pathways, after intense studies of the influence of calpain activity on drug-induced apoptosis, seems especially important lately, as calpains have become noticed as potential therapeutic targets. To allow pharmacological targeting of these enzymes, thorough knowledge of their patterns of activation and further interactions with already known apoptotic pathways is necessary. A comprehensive summary of both well established and recently obtained information in the field is an important step that may lead to future advances in the use of calpain-targeted agents in the clinic.
Keywords
Publisher

Year
Volume
58
Issue
3
Pages
287-296
Physical description
Dates
published
2011
received
2010-12-01
revised
2011-07-11
accepted
2011-08-19
(unknown)
2011-08-29
Contributors
  • Department of Pathophysiology, Medical University of Gdańsk, Gdańsk, Poland
  • Department of Pathophysiology, Medical University of Gdańsk, Gdańsk, Poland
References
  • Al-Bahlani S, Fraser M, Wong AYC, Sayan BS, Bergeron R, Melino G et al. (2011) P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism. Oncogene Published online 25 April 2011 [Epub ahead of print].
  • Altznauer F, Conus S, Cavalli A, Folkers G, Simon HU (2004) Calpain-1 Regulates Bax and Subsequent Smac-dependent Caspase-3 Activation in Neutrophil Apoptosis. J Biol Chem 279: 5947-5957.
  • Ben-Aharon I, Bar-Yosef H, Rizel S, Sulkes A, Stemmer SM, Shalgi R (2008) Doxorubicin induced apoptosis in oocytes - Mechanism and possible executers. J Clin Oncol 26, 2008 ASCO Annual Meeting, Abstract No 9611.
  • Benard J, Douc-Rasy S, Ahomadegbe JC (2003) TP53 family members and human cancers. Hum Mutat 21: 182-91.
  • Bi X, Rong Y, Chen J, Dang S, Wang Z et al. (1998) Calpain-mediated regulation of NMDA receptor structure and function. Brain Res 790: 245-253.
  • Blomgren K, Zhu C, Wang X, Karlsson JO, Leverin AL, Bahr BA et al. (2001) Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of 'pathological apoptosis'? J Biol Chem 276: 10191-10198.
  • Braun C, Engel M, Seifert M, Theisinger B, Seitz G et al. (1999) Expression of calpain I messenger RNA in human renal cell carcinoma: Correlation with lymph node metastasis and histological type. Int J Cancer 84: 6-9.
  • Burlacu A (2003) Regulation of apoptosis by Bcl-2 family proteins. J Cell Mol Med 7: 249-257.
  • Cao G, Xing J, Xiao X, Liou AKF, Gao Y, Yin XM et al. (2007) Critical role of calpain I in mitochondrial release of apoptosis-inducing factor in ischemic neuronal injury J Neurosci 27: 9278-9293.
  • Cao X, Deng X, May WS (2003) Cleavage of Bax to p18 Bax accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 Bax. Blood 102: 2605-2614.
  • Chen M, He H, Zhan S, Krajewski S, Reed JC, Gottlieb RA (2001) Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion J Biol Chem 276: 30724-30728.
  • Chipuk JE, Green DR (2008) How do Bcl-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 18: 157-164.
  • Choi WS, Lee EH, Chung CW, Jung YK, Jin BK, Kim SU et al. (2001) Cleavage of Bax is mediated by caspase-dependent or -independent calpain activation in dopaminergic neuronal cells: protective role of Bcl-2. J Neurochem 77: 1531-1541.
  • Chua BT, Guo K., Li P (2000) Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases. J Biol Chem 275: 5131-5135.
  • Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116: 205-219.
  • Das A, Sribnick EA, Wingrave JM, Del Re AM, Woodward JJ, Appel SH et al. (2005) Calpain activation in apoptosis of ventral spinal cord 4.1 (VSC4.1) motoneurons exposed to glutamate: calpain inhibition provides functional neuroprotection. J Neurosci Res 81: 551-562.
  • Das A, Banik NL, Ray SK (2006) Mechanism of apoptosis with the involvement of calpain and caspase cascades in human malignant neuroblastoma SH-SY5Y cells exposed to flavonoids. Int J Cancer 119: 2575-2585.
  • Del Bello B, Moretti D, Gamberucci A, Maellaro E (2007) Cross-talk between calpain and caspase-3/-7 in cisplatin-induced apoptosis of melanoma cells: a major role of calpain inhibition in cell death protection and p53 status. Oncogene 26: 2717-2726.
  • Demarchi F, Bertoli C, Greer P A, Schneidre C (2005) Ceramide triggers an NF-κB-dependent survival pathway through calpain. Cell Death Differ 12: 512-522.
  • Dibbert B, Weber M, Nikolaizik WH, Vogt P, Schöni MH, Blaser K et al. (1999) Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: A general mechanism to accumulate effector cells in inflammation. Proc Natl Acad Sci USA 96: 13330-13335.
  • Di Rosa G, Odrijin T, Nixon RA, Arancio O (2002) Calpain inhibitors: a treatment for Alzheimer's disease. J Mol Neurosci 19: 135-41.
  • Donkor IO, Korukonda R, Huang TL, LeCour L Jr. (2003) Peptidyl aldehyde inhibitors of calpain incorporating P2-proline mimetics. Bioorg Med Chem Lett 13: 783-784.
  • Franco SJ, Rodgers MA, Perrin BJ, Han J, Bennin DA et al. (2004) Calpain-mediated proteolysis of talin regulates adhesion dynamics. Nature Cell Biology 6: 977-983.
  • Gao G, Dou QP (2000) N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome c release and apoptotic cell death. J Cell Biochem 80: 53-72 .
  • Gawad A, Ptak-belowska A, Brzozowski T, Pwlik WW (2009) Monocytes and vascular endothelial cells apoptosis. Role of P-Hsp27. J Physiol Pharmacol 60: 55-61.
  • Goll DE, Thompson VF, Li H, Wei W, Cong J (2003) The calpain system. Physiol Rev 83: 731-801.
  • Gonen H, Shkedy D, Barnoy S, Kosover NS, Ciechanover A (1997) On the involvement of calpains in the degradation of the tumor suppressor protein p53. FEBS Letters 406: 17-22.
  • Goping IS, Gross A, Lavoie JN, Nguyen M, Jemmerson R, Roth K et al. (1998) Regulated targeting of BAX to mitochondria. J Cell Biol 143: 207-215.
  • Green D (2000) Apoptotic pathways: paper wraps stone blunts scissors. Cell 102: 1-4.
  • Guan N, Korukonda R, Hurh E, Schmittgen TD, Donkor IO, Dalton JT (2006) Apoptosis induced by novel aldehyde calpain inhibitors in human tumor cell lines. Int J Oncol 29: 655-663.
  • Guroff G (1964) A neutral calcium-activated proteinase from the soluble fraction of rat brain. J Biol Chem 239: 149-155.
  • Han Y, Weinman S, Boldogh I, Walker RK, Brasier AR (1999) Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation. J Biol Chem 274: 787-794.
  • Higuchi M, Takano J, Iwata N, Sekiguchi M, Saido TC (2002) Contribution of calpains and caspases to Abeta-induced neuritic and synaptic pathologies in Alzheimer's disease patients and amyloid precursor protein transgenic mice. Neurobiol Aging 25 (Suppl 2): S163.
  • Hirai S, Kawasaki H, Yaniv M, Suzuki K (1991) Degradation of transcription factors, c-Jun and c-Fos, by calpain. FEBS Lett 287: 57-61.
  • Hu H, Li X, Li Y, Wang L, Mehta S, Feng Q et al. (2009) Calpain-1 induces apoptosis in pulmonary microvascular endothelial cells under septic conditions Microvasc Res 78: 33-39.
  • Huston RB, Krebs EG (1968) Activation of skeletal muscle phosphorylase kinase by Ca2+. II. Identification of the kinase activating factor as a proteolytic enzyme. Biochemistry 7: 2116-2122.
  • Jang YM, Kendaiah S, Drew B, Phillips T, Selman C, Julian D et al. (2004) Doxorubicin treatment in vivo activates caspase-12 mediated cardiac apoptosis in both male and female rats. FEBS Lett 577: 483-90
  • Kato M, Nonaka T, Maki M, Kikuchi H, Imajoh-Ohmi S (2000) Caspases cleave the amino-terminal calpain inhibitory unit of calpastatin during apoptosis in human Jurkat T cells. J Biochem (Tokyo) 127: 297-305.
  • Khanna K., Lavin MF, Watters DJ (1998) Calpain activation is upstream of caspases in radiation-induced apoptosis. Cell Death Differ 5: 1051-1061.
  • Kiuchi K, Kiuchi K, Titani K, Fujita K, Suzuki K et al. (1991) Limited proteolysis of tyrosine hydroxylase by Ca2+-activated neutral protease (calpain). Biochemistry 30: 10416-10419.
  • Kim JS, Lee JH, Jeong WW, Choi DH, Cha HJ, Kim DH et al. (2008) Reactive oxygen species-dependent EndoG release mediates cisplatin-induced caspase-independent apoptosis in human head and neck squamous carcinoma cells. Int J Cancer 122: 672-680.
  • Kobayashi S, Yamashita K, Takeoka T, Ohtsuki T, Suzuki Y, Takahashi R et al. (2002) Calpain-mediated X-linked inhibitor of apoptosis degradation in neutrophil apoptosis and its impairment in chronic neutrophilic leukemia. J Biol Chem 277: 33968-33977.
  • Korukonda R, Guan N, Dalton JT, Liu J, Donkor IO (2006) Synthesis, calpain inhibitory activity, and cytotoxicity of P2-substituted proline and thiaproline peptidyl aldehydes and peptidyl alpha-ketoamides. J Med Chem 49: 5282-90.
  • Kouba DJ, Nakano H, Nishiyama T, Kang J, Uitto J, Mauviel A (2001) Tumor necrosis factor alpha induces distinctive NFκB signalling within human dermal fibroblasts. J Biol Chem 276: 6214-6224.
  • Kubbutat MH, Vousden KH (1997) Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability Mol Cell Biol 17: 460-468.
  • Kusakawa G, Saito T, Onuki R, Ishiguro K, Kishimoto T, Hisanaga S (2000) Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. J Biol Chem 275: 17166-17172.
  • Kuwako K, Nishimura I, Uetsuki T, Saido TC, Yoshikawa K (2002) Activation of calpain in cultured neurons overexpressing Alzheimer amyloid precursor protein. Brain Res Mol Brain Res 107: 166-175.
  • Lakshmikuttyamma A, Selvakumar P, Kanthan R, Kanthan SC, Sharma RK (2004) Overexpression of m-calpain in human colorectal adenocarcinomas. Cancer Epidemiol Biomarkers Prev 13: 1604-1609
  • Lee MS, Kwon YT, Li M, Peng J, Friedlander RM (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405: 360-364.
  • Lichtner M, Mengoni F, Mastroianni CM, Sauzullo I, Rossi R, De Nicola M et al. (2006) HIV protease inhibitor therapy reverses neutrophil apoptosis in AIDS patients by direct calpain inhibition. Apoptosis 11: 781-787.
  • Linder S, Shoshan MC (2005) Lysosomes and endoplasmic reticulum: targets for improved, selective anticancer therapy. Drug Resist Updat 8: 199-204.
  • Liu F, Grundke-Iqbal I, Iqbal K, Oda Y, Tomizawa K et al. (2005) Truncation and activation of calcineurin A by calpain l in Alzheimer disease brain. J Biol Chem 280: 37755-37762.
  • Liu L, Xing D, Chen WR, Chen T, Pei Y, Gao X (2008) Calpain-mediated pathway dominates cisplatin induced apoptosis in human lung adenocarcinoma cells as determined by real-time single cell analysis. Int J Cancer 122: 2210-2222.
  • Liu L, Xing D, Chen WR (2009) Micro-calpain regulates caspase-dependent and apoptosis inducing factor-mediated caspase-independent apoptotic pathways in cisplatin-induced apoptosis. Int J Cancer 125: 2757-2766.
  • Lu T, Xu Y, Mericle MT, Mellgren LR (2002) Participation of the conventional calpains in apoptosis. Biochim Biophys Acta 1590: 16-26.
  • Mamoune A, Luo JH, Lauffenburger DA, Wells A (2003) Calpain-2 as a target for limiting prostate cancer invasion. Cancer Res 63: 4632-4640.
  • Mandic A, Hansson J, Linder S, Shoshan MC (2003) Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J Biol Chem 278: 9100-9106.
  • Mandic A, Viktorsson K, Strandberg L, Heiden T, Hansson J, Linder S et al. (2002) Calpain-mediated bid cleavage and calpain-independent bak modulation: two separate pathways in cisplatin-induced apoptosis. Mol Cell Biol 22: 3003-3013.
  • McCollum AT, Nasr P, Estus S (2002) Calpain activates caspase-3 during UV-induced neuronal death but only calpain is necessary for death. J Neurochem 82: 1208-1220.
  • McGinnis KM, Gnegy ME, Park YH, Mukerjee N, Wang KKW (1999) Procaspase-3 and poly(ADP)ribose polymerase (PARP) are calpain substrates. Biochem Biophys Res Commun 263: 94-99.
  • Melino G, De Laurenzi V, Vousden KH (2002) p73: friend or foe in tumorigenesis, Nat Rev Cancer 2: 605-615.
  • Melino G, Lu X, Gasco M, Crook T, Knight RA (2003) Functional regulation of p73 and p63: development and cancer, Trends Biochem Sci 28: 663-670.
  • Mikosik A, Zaremba A, Puchalska Z, Daca A, Smolenska Z, Lopatniuk P et al. (2007) Ex vivo measurement of calpain activation in human peripheral blood lymphocytes by detection of immunoreactive products of calpastatin degradation. Folia Histochem Cytobiol 45: 343-347.
  • Moore JD , Rothwell NJ, Gibson RM (2002) Involvement of caspases and calpains in cerebrocortical neuronal cell death is stimulus-dependent. Br J Pharmacol 135: 1069-1077.
  • Mouatt-Prigent A, Karlsson JO, Agid Y, Hirsch EC (1996) Increased m-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? Neuroscience 73: 979-987.
  • Munarriz E, Bano D, Sayan AE, Rossi M, Melino G, Nicotera P (2005) Calpain cleavage regulates the protein stability of p73. Biochem Biophys Res Commun 333: 954-60.
  • Nakagawa T, Yuan J (2000) Cross-talk between two cysteine proteases families: activation of caspase-12 by calpain in apoptosis J Cell Biol 150: 887-894.
  • Neffe AT, Abell AD (2005) Developments in the design and synthesis of calpain inhibitors. Curr Opin Drug Discov Devel 8: 684-700.
  • Neumar RW, Xu AY, Gada H, Guttmann RP, Siman R (2003) Cross-talk between calpain and caspase proteolytic systems during neuronal apoptosis J Biol Chem 278: 14162-7
  • Oda A, Wakao H, Fujita H (2002) Calpain is a signal transducer and activator of transcription (STAT) 3 and STAT5 protease. Blood 99: 1850-1852.
  • Panaretakis T, Pokrovskaja K, Shoshan MC, Grandér D (2002) Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin. J Biol Chem 277: 44317-44326.
  • Perrin BJ, Huttenlocher A (2002) Calpain. Int J of Biochem and Cell Biol 34: 722-725.
  • Pfeifer D, Gao J, Adell G, Sun X-F (2006) Expression of the p73 protein in rectal cancers with or without preoperative radiotherapy. Int J Radiat Oncol Biol Phys 65: 1143-1148.
  • Polster BM, Basañez G, Etxebarria A, Hardwick JM, Nicholls DG (2005) Calpain I induces cleavage and release of apoptosis-inducing factor from isolated mitochondria J Biol Chem 280: 6447-54.
  • Pörn-Ares MI, Samali A, Orrenius S (1998) Cleavage of the calpain inhibitor, calpastatin, during apoptosis. Cell Death Differ 5: 1028-1033.
  • Pozniak CD, Barnabé-Heider F, Rymar VV, Lee AF, Sadikot AF, Miller FD (2002) P73 is required for survival and maintenance of CNS neurons. J Neurosci 22: 9800-9809.
  • Rami A, Agarwal R, Spahn A (2007) Synergetic effects of caspase 3 and mu-calpain in XIAP-breakdown upon focal cerebral ischemia. Neurochem Res 32: 2072-2079.
  • Ray SK, Wilford GG, Crosby CV, Hogan EL, Banik NL (1999) Diverse stimuli induce calpain overexpression and apoptosis in C6 glioma cells. Brain Res 829: 18-27.
  • Ray SK , Patel SJ, Welsh CT, Wilford GG, Hogan EL, Banik NL (2002) Molecular evidence of apoptotic death in malignant brain tumors including glioblastoma multiforme: Upregulation of calpain and caspase-3. J Neurosci Res 69: 197-206.
  • Reed J (1998) Bcl-2 family proteins. Oncogene 17: 3225-3236.
  • Roberts-Lewis JM, Marcy VR, Zhao Y, Vaught JL, Siman R, Lewis ME (1993) Aurintricarboxylic acid protects hippocampal neurons from NMDA- and ischemia-induced toxicity in vivo. J Neurochem 61: 378-381.
  • Ruiz-Vela A, González de Buitrago G, Martínez-A C (1999) Implication of calpain in caspase activation during B cell clonal deletion. EMBO J 18: 4988-4998.
  • Sahara S, Yamashima T (2010) Calpain-mediated Hsp.70 cleavage in hippocampal CA1 neuronal death. Biochem Biophys Res Commun 393: 806-811.
  • Saido TC, Sorimachi H, Suzuki K (1994) Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J 8: 814-822.
  • Saito K, Elce JS, Hamos JE, Nixon RA (1993) Widespread activation of calcium-activated neutral protease (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 90: 2628-2632.
  • Samantaray S, Ray SK, Ali SF, Banik NL (2006) Calpain activation in apoptosis of motoneurons in cell culture models of experimental parkinsonism. Ann N Y Acad Sci 1074: 349-56.
  • Samantaray S, Ray SK, Banik NL (2008) Calpain as a potential therapeutic target in Parkinson's disease. CNS Neurol Disord Drug Targets 7: 305-12
  • Sato-Kusubata K, Yajima Y, Kawashima S (2000) Persistent activation of Gsa through limited proteolysis by calpain. Biochem J 347: 733-740.
  • Schölzke MN, Potrovita I, Subramaniam S, Prinz S, Schwaninger M (2003) Glutamate activates NF-kappaB through calpain in neurons. Eur J Neurosci 18: 3305-3310.
  • Sedarous M, Keramaris E, O'Hare M, Melloni E, Slack RS, Elce JS et al. (2003) Calpains mediate p53 activation and neuronal death evoked by DNA damage J Biol Chem 278: 26031-26038.
  • Shirasaki Y, Miyashita H, Yamaguchi M (2006a) Exploration of orally available calpain inhibitors. Part 3: Dipeptidyl alpha-ketoamide derivatives containing pyridine moiety. Bioorg Med Chem 14: 5691-5698.
  • Shirasaki Y, Nakamura M, Yamaguchi M, Miyashita H, Sakai O, Inoue J (2006b) Exploration of orally available calpain inhibitors 2: peptidyl hemiacetal derivatives. J Med Chem 49: 3926-32.
  • Shirasaki Y, Yamaguchi M, Miyashita H (2006c) Retinal penetration of calpain inhibitors in rats after oral administration. J Ocul Pharmacol Ther 22: 417-424.
  • Sorimachi H, Ishiura S, Suzuki K (1997) Structure and physiological function of calpains Biochem J 328: 721-732.
  • Squier MKT, Miller ACK, Malkinson AM, Cohen JJ (1994) Calpain activation in apoptosis. J Cell Physiol 159: 229-237.
  • Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM et al. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397: 441-446.
  • Suzantova TG., Matskevich AA., Arkhipenko YV (1999) Calpains: physiological and pathophysiological significance. Pathophysiology 6: 981-102.
  • Takahashi H, Ichimiya S, Nimura Y, Watanabe M, Furusato M, Wacui S et al. (1998) Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma. Cancer Res 58: 2076-2077.
  • Tan Y, Chao W, De Veyra T, Greer PA (2006) Ubiquitous calpains promote both apoptosis and survival signals in response to different cell death stimuli. J Biol Chem 281: 17689-17698.
  • Tan Y, Dourdin N, Wu C, De Veyra T, Elce JS, Greer PA (2006) Ubiquitous calpains promote caspase-12 and JNK activation during endoplasmic reticulum stress-induced apoptosis. J Biol Chem 281: 16016-16024.
  • Tannapfel A, Engeland K, Weinans L, Katalinic A, Hauss J, Mössner J et al. (1999) Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver. Br J Cancer 80: 1069-1074.
  • Tompa P, Bruzdes-Lantes P, Tantos A, Farkas A, Szilagyi A et al. (2004) On the sequential determinants of calpain cleavage. J Biol Chem 279: 20775-20785.
  • Vaisid T, Kosower NS, Katzav A, Chapman J, Barnoy S (2007) Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease. Neurochem Int 51: 391-397.
  • Wang JZ, Liu F (2008) Microtubule-associated protein tau in development, degeneration and protection of neurons. Prog Neurobiol 85: 148-175.
  • Wang KK, Posmantur R, Nadimpalli R, Nath R, Mohan P, Nixon RA et al. (1998) Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis. Arch Biochem Biophys 356: 187-196.
  • Wang, KK (2000) Calpain and caspase: can you tell the difference? Trends Neurosci 23: 20-26.
  • Witkowski JM, Zmuda-Trzebiatowska E, Swiercz JM, Cichorek M, Ciepluch H, Lewandowski K et al. (2002) Modulation of the activity of calcium-activated neutral proteases (calpains) in chronic lymphocytic leukemia (B-CLL) cells. Blood 100: 1802-1809.
  • Wnuck Lipinski K, Keul P, Lucke S, Heusch G, Wohlschlaeger J, Baba HA et al. (2006) Degraded collagen induces calpain-mediated apoptosis and destruction of the X-chromosome-linked inhibitor of apoptosis (xIAP) in human vascular smooth muscle cells. Cardiovasc Res 69: 697-705.
  • Wood DE, Thomas A, Devi LA, Berman Y, Beavis RC, Reed JC et al. (1998) Bax cleavage is mediated by calpain during drug-induced apoptosis. Oncogene 17: 1069-1078.
  • Wood DE, Newcomb EW (1999) Caspase-dependent activation of calpain during drug-induced apoptosis. J Biol Chem 274: 8309-8315.
  • Yamashima T, Saido TC, Takita M, Miyazawa A, Yamano J, Miyakawa A et al. (1996) Transient brain ischemia provokes Ca2+, PIP2 and calpain responses prior to delayed neuronal death in monkeys Eur J Neurosci 8: 1932-44.
  • Yamashima T (2000) Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog Neurobiol 62: 273-295.
  • Zheng Y-L, Kesavapany S, Gravell M, Hamilton RS, Schubert M, Amin N, Albers W et al. (2005) A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons. Embo J 24: 209-20.
  • Zhu DM, Fang W-H, Narla RK, Uckun FM. (1999) A requirement for protein kinase C inhibition for calcium-triggered apoptosis in acute lymphoblastic leukemia cells. Clin Cancer Res 5: 355-360.
  • Zhu DM, Uckun FM (2000) Calpain inhibitor ii induces caspase-dependent apoptosis in human acute lymphoblastic leukemia and non-hodgkin's lymphoma cells as well as some solid tumor cells. Clin Cancer Res 6: 2456-2463.
  • Zhu W, Murtha PE, Young CY (1995) Calpain inhibitor-induced apoptosis in human prostate adenocarcinoma cells. Biochem Biophys Res Commun 214: 1130-1137.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.bwnjournal-article-abpv58p287kz
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.